A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer
Clinical trial NCT04732598 · COMPLETED
Trial details
- NCT number
- NCT04732598
- Sponsor
- Japanese Foundation for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-21
- Primary completion
- 2025-09-12
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.